Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.52
+0.48 (1.78%)
At close: May 5, 2026, 4:00 PM EDT
27.95
+0.43 (1.56%)
After-hours: May 5, 2026, 7:11 PM EDT
Genmab Stock Forecast
Stock Price Forecast
The 8 analysts that cover Genmab stock have a consensus rating of "Strong Buy" and an average price target of $39.56, which forecasts a 43.75% increase in the stock price over the next year. The lowest target is $32 and the highest is $48.
Price Target: $39.56 (+43.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $38 | Strong Buy | Maintains | $40 → $38 | +38.08% | Apr 30, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $32 | Buy | Initiates | $32 | +16.28% | Mar 27, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $40 | Buy | Initiates | $40 | +45.35% | Mar 2, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +45.35% | Feb 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +45.35% | Feb 18, 2026 |
Financial Forecast
Revenue This Year
4.39B
from 3.72B
Increased by 17.90%
Revenue Next Year
5.09B
from 4.39B
Increased by 16.05%
EPS This Year
11.98
from 15.37
Decreased by -22.03%
EPS Next Year
17.03
from 11.98
Increased by 42.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.7B | 5.6B | ||||||
| Avg | 4.4B | 5.1B | ||||||
| Low | 3.6B | 4.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 26.4% | 27.5% | ||||||
| Avg | 17.9% | 16.1% | ||||||
| Low | -2.5% | -4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.02 | 22.92 | ||||||
| Avg | 11.98 | 17.03 | ||||||
| Low | 9.61 | 11.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 23.7% | 91.3% | ||||||
| Avg | -22.0% | 42.1% | ||||||
| Low | -37.5% | -4.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.